GenScript Biotech Corporation, a global provider of life science research and manufacturing services, has been awarded a Silver Medal by EcoVadis, a globally recognized business sustainability assessment platform. This achievement places GenScript in the top 15% of companies worldwide assessed for their sustainability practices. The company, which is a member of the United Nations Global Compact and a supplier partner of the Pharmaceutical Supply Chain Initiative, has made significant advancements in areas such as environment, labor and human rights, ethics, and sustainable procurement. GenScript's sustainability efforts are further supported by an "A" rating from MSCI ESG Ratings, a "Low Risk" rating from Morningstar Sustainalytics, and inclusion in the FTSE4Good Index Series. The company's carbon reduction targets have been approved by the Science Based Targets initiative, emphasizing its commitment to addressing climate change.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.